Meticulous Research® Forecasts Cell Culture Market to Reach $48.63 Billion by 2029, Growing at a CAGR of 11.7%”

1. "Meticulous Research® Forecasts Cell Culture Market to Reach $48.63 Billion by 2029, Growing at a CAGR of 11.7%” J

2. Cell Culture Market 2022-2029 Meticulous Research®, a leading provider of market intelligence, has released a new comprehensive report titled “Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), End User (Pharma, Academic) - Global Forecast to 2029.” This report forecasts that the global cell culture market is poised for substantial growth, projected to expand at a Compound Annual Growth Rate (CAGR) of 11.7% from 2022 to 2029, reaching an estimated value of $48.63 billion by the end of the forecast period. Download Free Sample PDF Copy Here: https://www.meticulousresearch.com/download-sample- report/cp_id=4788?utm_source=article&utm_medium=social&utm_campaign =product&utm_content=20-08-2024 The cell culture market's impressive growth trajectory is driven by multiple factors, including the rapid expansion of the biopharmaceutical sector, a rising prevalence of chronic diseases, increased demand for monoclonal antibodies, a surge in research funding, and the growing adoption of single-use technologies. Additionally, the report highlights the expanding role of 3D cell culture and personalized medicine as key opportunities for market players in the coming years. • The COVID-19 Pandemic's Influence on Cell Culture Research The COVID-19 pandemic has had a profound impact on cell culture research activities. Early in the pandemic, understanding the dynamics of viral transmission and its potential for contagion was crucial for formulating effective infection control strategies. Researchers worldwide initiated extensive studies to explore the biology of various virus variants, leading to the development of new therapeutic interventions. In February 2020, the Centers for Disease Control and Prevention (CDC) provided global access to the SARS-CoV-2 virus strain, facilitating vital research efforts in the scientific and medical communities. In vitro cell culture models have been instrumental in advancing COVID-19 research, particularly in areas such as antiviral development, vaccine innovation, pathogenesis studies, and virus stability assessments. Human lung epithelium models and other cellular systems have been at the forefront of these endeavors, underscoring the pandemic's positive impact on the demand for cell culture products. • Market Segmentation Insights • By Product: The cell culture market is categorized into consumables and equipment. The consumables segment, comprising media, reagents, sera, and cell lines, accounted for the largest market share in 2022, driven by the increasing utilization of cell culture techniques across various applications. • By Application: The bioproduction segment dominated the market in 2022, attributed to the growing demand for biopharmaceutical products, including monoclonal antibodies, vaccines, therapeutic proteins, and gene therapies. • By End User: Pharmaceutical and biotechnology companies represented the largest market share in 2022, bolstered by the expansion of production facilities, increased research activities, and the presence of major industry players. • Geographical Insights Page 1 of 2 © Meticulous Research| sales@meticulousresearch.com

3. Cell Culture Market 2022-2029 The report provides an in-depth analysis of major geographic regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America led the global market in 2022, driven by a robust healthcare system, widespread adoption of advanced technologies, and a strong focus on pharmaceutical research and biopharmaceutical manufacturing capacity expansion. • Key Industry Players Prominent companies driving innovation and growth in the cell culture market include Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Cytiva (U.S.), Lonza Group Ltd. (Switzerland), Corning Incorporated (U.S.), Becton, Dickinson and Company (U.S.), Avantor, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), HiMedia Laboratories (India), Sartorius AG (Germany), Eppendorf SE (Germany), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (U.S.), Getinge AB (Sweden), Greiner Bio-One GmbH (Austria), and Miltenyi Biotec B.V. & Co. KG (Germany). Quick Buy @ https://www.meticulousresearch.com/Checkout/94004198?utm_source=articl e&utm_medium=social&utm_campaign=product&utm_content=20-08-2024 About Meticulous Research® Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 2 of 2 © Meticulous Research| sales@meticulousresearch.com